Viewing Study NCT03184571

Bugs

Ignite Creation Date: 2025-12-18 @ 8:45 AM

Ignite Modification Date: 2025-12-18 @ 8:45 AM

Study NCT ID: NCT03184571

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module